Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease—How to Choose

Aspirin-exacerbated respiratory disease (AERD) can be a frustratingly complex syndrome to treat. Until recently, standard medical and surgical therapies for patients' asthma and chronic rhinosinusitis with nasal polyposis were the primary treatment modalities available, combined with either com...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2022-06, Vol.10 (6), p.1462-1467
Hauptverfasser:	Laidlaw, Tanya M., Chu, Derek K., Stevens, Whitney W., White, Andrew A.
Format:	Artikel
Sprache:	eng
Schlagworte:	AERD Allergies Aspirin Aspirin desensitization Aspirin-exacerbated respiratory disease Asthma Benralizumab Biological products Biologics Chronic rhinosinusitis Clinical trials CRSwNP Desensitization (Psychology) Drug dosages Dupilumab Immunosuppressive agents Inflammation Mepolizumab Monoclonal antibodies Nasal polyps Nonsteroidal anti-inflammatory drugs Omalizumab Otolaryngology Patients Polyposis Polyps Quality of life Respiratory diseases Rhinitis Rhinosinusitis Sinuses Sinusitis Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!